This study showed that piR-DQ590027 was lowly expressed in glioma-conditioned ECs (GECs) and that piR-DQ590027 overexpression could decrease the expressions of ZO-1, occludin, and claudin-5 to further increase the permeability of glioma-conditioned normal BBB. Here, CLDN5 is linked to central nervous system cancer.